Brain death determination in patients with veno-arterial extracorporeal membrane oxygenation: A systematic study to address the Harlequin syndrome

Farid Salih,Johann Lambeck,Albrecht Günther,Caroline Ferse,Olaf Hoffmann,Konstantinos Dimitriadis,Andre Finn,Stephan A. Brandt,Benjamin Hotter,Florian Masuhr,Stephan Schreiber,Florian Weissinger,Andrea Rocco,Hauke Schneider,Wolf-Dirk Niesen,on behalf of the IGNITE study group
DOI: https://doi.org/10.1016/j.jcrc.2024.154545
IF: 4.298
2024-02-24
Journal of Critical Care
Abstract:Purpose The Harlequin syndrome may occur in patients treated with venoarterial extracorporal membrane oxygenation (VA-ECMO), in whom blood from the left ventricle and the ECMO system supply different parts of the body with different p a CO 2 -levels. The purpose of this study was to compare two variants of p a CO 2 -analysis to account for the Harlequin syndrome during apnea testing (AT) in brain death (BD) determination. Materials and methods Twenty-seven patients (median age 48 years, 26–76 years; male n = 19) with VA-ECMO treatment were included who underwent BD determination. In variant 1, simultaneous arterial blood gas (ABG) samples were drawn from the right and the left radial artery. In variant 2, simultaneous ABG samples were drawn from the right radial artery and the postoxygenator ECMO circuit. Differences in p a CO 2 -levels were analysed for both variants. Results At the start of AT, median p a CO 2 -difference between right and left radial artery (variant 1) was 0.90 mmHg (95%-confidence intervall [CI]: 0.7–1.3 mmHg). Median p a CO 2 -difference between right radial artery and postoxygenator ECMO circuit (variant 2) was 3.3 mmHg (95%-CI: 1.5–6.0 mmHg) and thereby significantly higher compared to variant 1 ( p = 0.001). At the end of AT, p a CO 2 -difference according to variant 1 remained unchanged with 1.1 mmHg (95%-CI: 0.9–1.8 mmHg). In contrast, p a CO 2 -difference according to variant 2 increased to 9.9 mmHg (95%-CI: 3.5–19.2 mmHg; p = 0.002). Conclusions Simultaneous p a CO 2 -analysis from right and left distal arterial lines is the method of choice to reduce the risk of adverse effects (e.g. severe respiratory acidosis) while performing AT in VA-ECMO patients during BD determination.
critical care medicine
What problem does this paper attempt to address?